Rein Therapeutics
(NASDAQ) RNTX
Rein Therapeutics Financials at a Glance
Market Cap
$84.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$50.21M
EPS (TTM)
-$1.91
P/E Ratio
-0.52
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$1.03
Volume
162,341
Open
$0.98
Price
$1.03
Volume
162,341
Open
$0.98
Previous Close
$1.03
Daily Range
$0.95 - $1.03
52-Week Range
$0.86 - $2.18
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$1.03
Volume
162,341
Open
$0.98
Previous Close
$1.03
Daily Range
$0.95 - $1.03
52-Week Range
$0.86 - $2.18
Estimated Earnings Date
Aug 13, 2026
RNTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rein Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
Brian J. Windsor, PhD
Website
www.reintx.comHeadquarters
Austin, TX 78758, US
RNTX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-258.45%
Return on Capital
-129.63%
Return on Assets
-190.99%
Earnings Yield
-1.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$84.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
85.54M
Volume
162.34K
Avg. Volume
789.64K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$21.55M
EBITDA
-$21.49M
Operating Cash Flow
-$16.61M
Capital Expenditure
$0.00
Free Cash Flow
-$16.61M
Cash & ST Invst.
$4.45M
Total Debt
$4.92M
Rein Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$84.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$7.71M
N/A
Employees
11
N/A
Net Income
-$5.84M
-6.1%
EBITDA
-$5.22M
+5.2%
Quarterly Fundamentals
Total Cash
$4.45M
-40.2%
Total Debt
$4.92M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$4.92M
N/A
Return on Assets
-1.91%
N/A
Return on Invested Capital
-1.70%
N/A
Free Cash Flow
-$3.42M
+44.6%
Operating Cash Flow
-$3.42M
+44.6%